prefer explicit peptides, this general immunoreactivity term has declining use; kept for historical purposes; peptides which have an immunodeterminant similar to the 2-23 region of glucagon, but not immunodeterminant similar to glucagon; do not confuse with Gli1 protein which is a transcription factor
Also Known As:
big plasma glucagon; gut glucagon-like immunoreactants
Networked: 31 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Hypoglycemia (Reactive Hypoglycemia)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
02/01/1985 - "In the present study we characterized and compared the different molecular forms of glucagon-like immunoreactivity in extracts of peripheral plasma and hepatic metastases of a patient with pancreatic alpha-cell tumor. "
02/01/1985 - "Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor."
02/01/1985 - "The results clearly demonstrated that both plasma and glucagon-like immunoreactivity extracted from hepatic metastases were heterogeneous and comprised species corresponding not only to "true" glucagon but also to higher mol wt forms. "
02/01/1985 - "Total plasma glucagon-like immunoreactivity prior to surgery was 26.64 nmol/l and consisted of four peaks of immunoreactivity of apparent 9,000 mol wt, 5,800-5,400 mol wt, and 4,000 mol wt. Total glucagon-like immunoreactivity extracted from the hepatic metastasis was 47.41 nmol/g wet weight and eluted as two major peaks of immunoreactivity as follows: peak I, mol wt 3,800, corresponding to "true" 3,500 mol wt glucagon; peak II, mol wt 1,400, probably consisted of glucagon degradation products. "
10/15/1987 - "After a review of the literature on this subject, this case is believed to be highly unusual in several respects: (1) despite their small size, these tumors resulted in multiple metastases to the regional lymph nodes; (2) both primary tumors and metastases were extensively and strongly argentaffin; and (3) most tumors and metastases contained, when investigated by immunocytochemistry, several biologically active substances such as serotonin, somatostatin, and glucagon-like immunoreactivity."
4. Shock
5. Chronic Pancreatitis

Related Drugs and Biologics

1. Glucagon (Glukagon)
2. Insulin (Novolin)
3. Glucose (Dextrose)
4. Glicentin
5. Blood Glucose (Blood Sugar)
6. Substance P
7. Somatostatin (Somatotropin Release-Inhibiting Factor)
8. Pancreatic Polypeptide (Pancreatic Polypeptide (PP))
9. Gastrins
10. Glucagon-Like Peptides (Enteroglucagon)

Related Therapies and Procedures

1. Cardiopulmonary Resuscitation (CPR)
2. Intravenous Infusions
3. Denervation